Skip to Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

16 November 2026

30 Pages

Cardiovascular Risk Assessment Across the Female Life Course: Key Time Windows for Earlier Identification and Prevention

,
,
,
,
,
,
,
,
…
1
Division of Cardiology, Policlinico Casilino, 00169 Rome, Italy
2
Service de Cardiologie, Hôpital Saint Joseph, 75014 Paris, France
3
Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy
4
ACTION Group, INSERM UMRS1166, Département of Cardiology, Hôpital Pitié-Salpêtrière (AP-HP), Sorbonne Université, 75013 Paris, France
J. Cardiovasc. Dev. Dis.2026, 13(11), 601;https://doi.org/10.3390/jcdd13110601 
(registering DOI)
This article belongs to the Special Issue Cardiovascular Risk Factors in Women

Abstract

Cardiovascular disease remains the leading cause of death in women, yet risk is frequently underestimated, particularly during early and middle adulthood. A life-course perspective may identify periods in which female-specific factors reveal or accelerate cardiovascular vulnerability. This narrative review examines cardiovascular risk across adolescence, reproductive life, pregnancy, the postpartum period, menopause, and older age. Relevant literature was identified through a targeted PubMed search, supplemented by major international guidelines and reference screening. The review addresses reproductive and pregnancy-related risk factors, female-predominant conditions, limitations of current prediction models, and the potential contribution of biomarkers and imaging, including coronary artery calcium and breast arterial calcification. Cardiovascular prevention in women should move beyond isolated 10-year risk estimates towards longitudinal assessment that incorporates reproductive history and female-specific risk modifiers. Pregnancy and the postpartum period are underused opportunities for early prevention, whereas selected imaging tools may improve risk classification when conventional scores are uncertain. Future progress will require structured follow-up pathways, multidisciplinary care, systematic capture of female-specific risk factors, and prediction models validated in diverse female populations. We distinguish epidemiological associations from independently validated risk prediction and from interventions with demonstrated clinical benefit, and propose a staged, guideline-anchored pathway for reassessment at key life transitions.

Article Metrics

Citations

Article Access Statistics

Article metric data becomes available approximately 24 hours after publication online.